Home Biogen Idec wins Canadian approval for hemophilia drug Alprolix
 

Keywords :   


Biogen Idec wins Canadian approval for hemophilia drug Alprolix

2014-03-21 15:39:52| Biotech - Topix.net

Hemophilia B, a rare inherited disorder in which the ability of a person's blood to clot is impaired, affects some 4,000 people in the United States and roughly 25,000 worldwide.

Tags: drug approval canadian wins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11 NEXT
23.11
23.11(Rawlings)
23.11 DVD2
23.11
23.11 US Orig LP The Soul Searchers Salt Of ~
23.11Switch SR SL LED 2
More »